Guardion Health Sciences Inc represents a strong commitment to advancing ocular health and wellness. The company's corporate philosophy revolves around the development and commercialization of diagnostic technologies and medical food supplements that support the overall well-being of the eyes. Guardion Health Sciences Inc places great importance on research and innovation to provide cutting-edge solutions for patients with macular degeneration and other ocular conditions. By leveraging their expertise in nutrition and diagnostics, Guardion Health Sciences Inc aims to enhance vision and improve the quality of life for individuals globally.

Guardion Health Sciences Inc is primarily present in the United States.

Guardion Health Sciences Inc has achieved several significant milestones. The company successfully developed and commercialized the first and only medical device, the MapcatSF® test, which measures macular pigment optical density. In addition, Guardion Health Sciences Inc created the LumiShield Plus® nutraceutical, a key supplement that supports eye health. The company also secured FDA registration for its medical devices and ISO 13485 certification for quality management systems. Guardion Health Sciences Inc continues to expand its partnerships and collaborations within the healthcare industry, demonstrating its commitment to advancing eye care and improving patient outcomes. With these achievements, Guardion Health Sciences Inc is positioned for continued growth and success in the future.

Guardion Health Sciences Inc is a leading healthcare company specializing in the development and commercialization of diagnostic tests and nutritional products. Founded in 2009, Guardion Health Sciences Inc has established a strong reputation for its groundbreaking research and innovation in the field of ocular health. The company aims to improve patient outcomes by providing personalized, evidence-based solutions for the management of chronic diseases. Guardion Health Sciences Inc has garnered recognition for its flagship product, the Medical Food Lumega-Z, which is designed to support and maintain healthy macular pigment levels. With a commitment to scientific excellence, Guardion Health Sciences Inc continues to play a pivotal role in advancing the field of nutrition-based healthcare.

The main competitors of Guardion Health Sciences Inc in the market include companies like EyePoint Pharmaceuticals Inc, Novartis AG, and DexCom Inc.

Guardion Health Sciences Inc is primarily active in the healthcare industry.

Guardion Health Sciences Inc is a company with a business model focused on developing and commercializing medical technologies. Their primary focus lies in the enhancement and preservation of human vision, offering patients and healthcare providers innovative solutions. With a strong emphasis on personalized approaches, Guardion Health Sciences Inc aims to provide diagnostic tests, medical devices, and nutritional products to support eye health. Through extensive research and collaboration with healthcare professionals, they strive to address various eye conditions and improve overall patient outcomes.

P/E odnos Guardion Health Sciences iznosi -1,24.

KUV kompanije Guardion Health Sciences iznosi 0,30.

AlleAktien kvalitativni skor za Guardion Health Sciences je 6/10.

očekivana Guardion Health Sciences promet je 13,72 mil. USD.

Dobit očekivana Guardion Health Sciences je -3,30 mil. USD.

Guardion Health Sciences Inc is a company specializing in the development and marketing of products and technologies for the healthcare industry. The company is headquartered in San Diego, California, and is listed on the NASDAQ stock exchange under the ticker GHSI. Guardion Health Sciences Inc operates in two different divisions, both aimed at improving people's visual health. The first division is the diagnosis and treatment of age-related macular degeneration (AMD), an eye disease that can lead to loss of vision. Guardion Health Sciences Inc has developed a product called "MapcatSF" that allows for accurate diagnosis of AMD. The product is based on a technology that measures the metabolism of the retina in the eye. This allows for the detection and timely treatment of changes in metabolism. MapcatSF is a safe and easy-to-use procedure used by ophthalmologists worldwide. The second division of Guardion Health Sciences Inc is the development of dietary supplements for visual health. The company has two products on the market, Lumega-Z and GlaucoCetin. Lumega-Z is a product developed based on clinical studies that helps to compensate for the lack of essential nutrients important for retinal health in the eye. Lumega-Z contains special carotenoids naturally occurring in the retina of the eye, which provide protection against harmful UV rays. GlaucoCetin is another dietary supplement specifically developed for the treatment of glaucoma. It contains a special blend of natural antioxidants and anti-inflammatory compounds that can help lower intraocular pressure in the eye. Guardion Health Sciences Inc is a company dedicated to improving people's visual health worldwide. The company works closely with leading ophthalmologists and researchers to develop the latest technologies and procedures that enable accurate diagnosis and treatment of eye diseases. In addition, Guardion Health Sciences Inc has a strong presence in the research and development of dietary supplements for visual health. The business model of Guardion Health Sciences Inc is based on marketing products and technologies for the healthcare industry. The company aims to sell its products worldwide by expanding its distribution channels and exploring new business opportunities. Guardion Health Sciences Inc also works closely with the medical community to advance research and development of new products and technologies and strengthen its market position. In summary, Guardion Health Sciences Inc is a company dedicated to visual health and continuously working to develop new products and technologies to improve retinal health in the eye. The company operates in two main divisions, the diagnosis and treatment of AMD, and the development of dietary supplements for visual health. Guardion Health Sciences Inc is an innovative company that holds a strong leadership position in the visual health market. Answer: Guardion Health Sciences Inc is a company specializing in the development and marketing of products and technologies for the healthcare industry, with a focus on improving visual health.

Guardion Health Sciences isplaćuje dividendu od 0 USD raspoređenu preko isplata u toku godine.

Dividenda za Guardion Health Sciences trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Guardion Health Sciences je US40145Q4010.

WKN od Guardion Health Sciences je A2QQR4.

Oznaka za praćenje akcija kompanije Guardion Health Sciences je GHSI.

U poslednjih 12 meseci, Guardion Health Sciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Guardion Health Sciences će verovatno isplatiti dividendu od 0 USD.

Dividendski prinos od Guardion Health Sciences trenutno iznosi .

Guardion Health Sciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Guardion Health Sciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

Guardion Health Sciences se svrstava u sektor 'Neciklička potrošnja'.

Da biste primili poslednju dividendu od Guardion Health Sciences od 23. 9. 2024. u iznosu od 5 USD, morali ste da imate akciju u depou pre Ex-dana 24. 9. 2024..

Isplata poslednje dividende izvršena je 23. 9. 2024..

U godini 2023 kompanija Guardion Health Sciences je isplatila 0 USD kao dividende.

Dividende od Guardion Health Sciences se isplaćuju u USD.